[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]amine hydrobromide, 95.0%, 1g

Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1), 99%, 50mg

1-Cyclopropyl-1-phenylmethanamine hydrochloride, 95.0%, 500mg

N,N-dimethylacetamide, min. 99%, for synthesis, 25 l, plastic packaging.

7-Amino-4,4-dimethyl-1,2,3,4-tetrahydroquinazolin-2-one, >95%, 1g

2-BROMO-6-NITRO-4-TERT-BUTYLPHENOL, 97.0%, 10g

Methyl 3-((tert-butoxycarbonyl)amino)pyrrolidine-3-carboxylate, 95%, 100mg

Naringin, min. 98%, 50 g, plastic packaging.

2-Amino-2-(4-bromophenyl)acetic acid, 95.0%, 100mg

3-(2,3-Dimethoxyphenyl)propanoic acid, 95.0%, 25g

2-(4-methoxyphenyl)propan-2-amine, 95.0%, 1g

Palladium (10%) on activated carbon, 10% Pd/C with approx. 60% water, 1 g, glass packaging

5-ethenyl-1,2-dihydropyridin-2-one, 98%, 500mg